Serum heavy-light chain analysis (Hevylite): clinical applications for multiple myeloma

Similar documents
Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory

ABC of laboratory techniques for diagnosis and follow-up of monoclonal gammopathies. An Hendrickx MSc. Scientific Advisor

Freelite & Hevylite. Together Freelite & Hevylite catch more monoclonal gammopathy patients. The Specialist Protein Company

Intact immunoglobulin heavy/light chain paired assays

Measuring Myeloma in the LAB. BL Ferry Clinical Lead Sept 15 th 2014

Guidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology

Freelite & Hevylite. Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies

Applicazioni della misura delle Free Light Chain nella pratica clinica. Maria Teresa Petrucci

Introduction. Point. Keywords: electrophoresis; Hevylite; IgA; immunoglobulin; monoclonal protein.

Immunoglobulin / free light chain ratio

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies

Serum Free Light Chain Assays

Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins

Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities

IgA Kappa/IgA Lambda Heavy/Light Chain Assessment in the Management of Patients With IgA Myeloma

Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays

What do you do, with an M protein?

Elevated Immunoglobulins and Paraproteins

Southern Derbyshire Shared Care Pathology Guidelines. Diagnosis and Management of Myeloma

serum FLC concentration was available twice as often as a measurable urine M-spike American Association for Clinical Chemistry

Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels

June Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD

Laboratories and the New IMWG Myeloma Guidelines

Supplementary Appendix

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples

Report of Survey conducted by IFCC WG Harmonisation of Interpretive Commenting EQA (WG-ICQA) subgroup:

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Mar; 160(1): microglobulin (β 2

Prognostic utility of intact immunoglobulin Ig 0 k/ig 0 l ratios in multiple myeloma patients

Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin / Ratios

Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population

WG-ICQA Harmonisation of Interpretive Commenting EQA

e-issn X Modern Medical Laboratory Journal

EDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS

Diagnosis and Current Standard Treatments for Multiple Myeloma. Natalie S. Callander, M.D Professor of Medicine

Understanding Lab Values in Multiple Myeloma

Myeloma Primary Care. Dr R Lovell Feb 2015

ד"ר יעל דויטשר-צ'רטקוב,

Smoldering Multiple Myeloma

Leukemia (2013) 27, & 2013 Macmillan Publishers Limited All rights reserved /13

Evaluation of Sebia s Capillarys 2 flex-piercing system in. level monoclonal protein in serum and urine of patients

diag.of gammop Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS

Effective Health Care Program

Sharply Increased Serum Free Light-Chain Concentrations after Treatment for Multiple Myeloma

DIAGNOSIS OF MYELOMA BASED ON THE 2014 INTERNATIONAL MYELOMA WORKING GROUP

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma

Restrooms Cell phones on silent/vibrate. Refreshments. Patient resource materials

Current Issues in Pharmacy and Medical Sciences. journal homepage:

Current Issues in Pharmacy and Medical Sciences. journal homepage:

Diagnosis and staging

بسم اهلل الرمحن الرحيم

Electrophoresis. Assays... INTERLAB ASSAYS. Instrument. Software Easy data management thanks to innovative Elfolab software. General Characteristic

This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed.

Q1 What is your occupation/role? (select all that apply) Answered: 310 Skipped: 4 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Performance of the Sebia CAPILLARYS 2 for Detection and Immunotyping of Serum Monoclonal Paraproteins

Handout for lecture on plasma cell neoplasms presented by Rob McKenna

Analytically coherent

Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio

Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder

Brian GM Durie. Black Swan Research Initiative (BSRI) Purpose

Relatively Restricted Migration of Polyclonal IgG4 May Mimic a Monoclonal Gammopathy in IgG4-Related Disease

Available online at

Serum Free Light Chain (FLC) Analysis: A Guiding Light in Monoclonal Gammopathy Management

Parameswaran Hari Medical College of Wisconsin Milwaukee

Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma-Cell Dyscrasias

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Serum free light chain and Hevylite analyses in the diagnosis, monitoring and prognosis of B cell disorders

Hot Topic. Disclosures. None

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy

Accuracy of Serum IgM and IgA Monoclonal Protein Measurements by Densitometry

Serum Free Light Chain Analysis

Minimal Residual Disease assessment in Multiple Myeloma by Next-Generation Sequencing

IMMUNOCHEMICAL TECHNIQUES

Change Summary - Form 2116 (R3) 1 of 6

Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation

HEALTHTREE QUESTIONNAIRE

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Jerry A. Katzmann, 1* Raynell J. Clark, 1 Roshini S. Abraham, 1 Sandra Bryant, 1 James F. Lymp, 1 Arthur R. Bradwell, 2 and Robert A. Kyle 1.

The New England Journal of Medicine A LONG-TERM STUDY OF PROGNOSIS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE. Patients

SIGNIFICANCE OF GAMMA GLOBULINS IN MULTIPLE MYELOMA THROUGH SERUM ELECTROPHORETIC PATTERN

Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic IgM

Monitoring Multiple Myeloma

Diagnosis of multiple myeloma (MM) requires the examination

Polyclonal versus monoclonal immunoglobulin-free light chains quantification

The Importance of Establishing Baseline Disease Characteristics in Myeloma Diagnosis and Management

Understanding MGUS and Smoldering Multiple Myeloma

Management of Multiple Myeloma: The Changing Paradigm

Severe Isotype-Matched Immunosuppression (IMI) as a Potential Risk Factor for Progression of MGUS Patients

Suppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity

A rare case of non-secretory multiple myeloma: a case report and literature review

+ Serum Protein Electrophoresis with Immunofixation

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

Professor Mitch Dowsett. Dr Martin Kaiser Dr Robyn Shea Dr Robyn Shea. Molecular Pathology Biochemistry

Index. Quinzanini, M. Departments of Rheumatology, Immunology & Allergology, Azienda Ospedaliera Spedali Civili, Brescia, Italy

Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort

Monoclonal gammopathies overview and categorization

CHAPTER 3 ANTIBODY STRUCTURE I

SAS-MX IFE-1 Kit Instructions for Use

Transcription:

Serum heavy-light chain analysis (Hevylite): clinical applications for multiple myeloma Kelly Endean PhD Scientific Affairs Manager, The Binding Site

Focus of this talk An introduction to heavy-light chain (HLC) analysis & its benefits Hevylite in MGUS Prognosis Hevylite in multiple myeloma Presentation Monitoring Prognosis

Detection of Monoclonal Proteins Monoclonal Intact Immunoglobulins Serum electrophoresis or Serum HLC (Hevylite) Monoclonal Free Light Chains Urine electrophoresis or Serum FLC

IMWG guidelines: Multiple myeloma follow-up For patients with measurable monoclonal protein in serum, both electrophoretic studies and quantitative immunoglobulins are recommended to assess response, although electrophoretic measurements to follow monoclonal protein are preferred. Dimopoulos et al. 2011. Blood 117(18), 4701-4705.

Limitations of electrophoresis Some serum protein electrophoresis (SPE) results are difficult to interpret Broad bands & smearing of bands Couplet/ triplets of bands Precipitation at the point of application Dye saturation Hidden bands

NHS Problems with SPE densitometry IgA bands may be hidden by transferrin 14 IgA Multiple Myeloma sera Alb 1 2 1 2

IMWG guidelines: Multiple myeloma follow-up For patients with measurable monoclonal protein in serum, both electrophoretic studies and quantitative immunoglobulins are recommended to assess response, although electrophoretic measurements to follow monoclonal protein are preferred. For several patients, especially with IgA or IgD myeloma, nephelometric quantitation of serum immunoglobulin is necessary. Dimopoulos et al. 2011. Blood 117(18), 4701-4705.

Standard nephelometric IgG, IgA and IgM assays Total immunoglobulin measurements do not distinguish monoclonal from polyclonal proteins within any given sample e.g. Total IgG = IgG + IgG involved immunoglobulin + uninvolved immunoglobulin

Prognostic value of Hevylite in MGUS IgG Heavy-Light Chain Pair suppression is an indicator of progression from MGUS to MM IgA IgA Involved Ig & uninvolved Ig Katzmann et al. Blood 2009; 114: 1788

Prognostic value of Hevylite in MGUS IgG Heavy-Light Chain Pair Suppression is an indicator of progression from MGUS to MM IgA IgA HLC pair suppression Involved Ig & uninvolved Ig Katzmann et al. Blood 2009; 114: 1788

Study population of 999 MGUS patients Follow-up over 30 years HLC pair suppression is an independent risk factor for progression Katzmann et al Leukemia 2012

Presentation IgA IgG FcRn Monitoring Hevylite in MM IgG (Bradwell et al. 2009) IgA (Donato et al. 2011) Prognostication

Mirbahai et al. Presented at AACC 2011

NHS Problems with SPE densitometry IgA bands may be hidden by transferrin 14 IgA Multiple Myeloma sera 1 2 3 Alb 1 2 1 2

IgG MM patients have an abnormal IgG HLC ratio at presentation IgG (g/l) N = 245 IgG (g/l) Bradwell et al Leukemia 2012; doi: 10.1038/leu.2012.159

Hevylite IgG /IgG ratios Correct for variable IgG metabolism

Concentration-dependent catabolism of IgG

Presentation IgA IgG FcRn Monitoring Hevylite in MM IgG IgA (Donato et al. 2011) Prognostication

Avet-Loiseau et al. Haematologica 2011. 96(s1): P-393a

IgG HLC: Monitoring IgG MM IgG HLC ratio is normal when IFE is positive for some IgG patients? Hevylite ratio insensitive due to background IgG? IFE is false positive due to recycling by FcRN receptor

IgGk production by tumour IgGk serum concentration IFE positivity remains due to IgG recycling + + + + + + + IFE Short IgG half-life Prolonged IgG half-life Time

Discrepancies between IFE & bone marrow immunophenotype Discrepancies between the three techniques were relatively common... in all seven patients achieving IR [Bone marrow plasma cell immunophenotypic response] but remaining immunofixation positive, the M-component disappeared in follow-up analysis. Paiva et al. J Clin Oncol 2011;29:1627-33.

Clinical History 9 yr history of MGUS Presentation Anaemia and hypercalcaemia SPE - 48 g/l M protein IFE monoclonal IgAκ Raised total IgA (47.2g/L) Abnormal sflc κ/λ ratio (7) BM - 40% plasma cells Donato et al. Clin Chem. 2011;57(12):1645-8

Diagnosis MM (Durie-Salmon stg IIIA/Int stg 2) Treatment & monitoring Stem cell transplant Pt became asymptomatic Electrophoresis negative for 1.5 yrs 1 st relapse 2 yrs following ASCT Donato et al. Clin Chem. 2011;57(12):1645-8

Monoclonal proteins that migrate as broad bands can be difficult to distinguish, and quantitative assessment of immunoglobulin HLC pairs provides a measure of clonal synthesis. Donato et al. Clin Chem. 2011;57(12):1645-8 Commentary - James D. Faix, Stanford University Now it is clear that we have another alternative for cases like this.

IFM 2005-01 data courtesy of H. Avet-Loiseau

Presentation IgA IgG FcRn Monitoring Hevylite in MM IgG IgA (Donato et al. 2011) Prognostication

Extreme Hevylite ratios IgG IgG 0.001 0.01 0. 1 1.0 10 100 1000 IgG /G

Ludwig et al. Presented at ASH 2011

Any questions? kelly.endean@bindingsite.co.uk Chapter 32.7